Logo Align Technology

Align Technology (ALGN) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Align Technology · Health Care · ref. ETF XLV · 90 calls · price $158.84
🏆JPI 2026 portfoliosSee tracking →
What the company does: Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services.

📈 Align Technology (ALGN) stock price

$158.84+12.5% over range
Aug 28, 25low $124.88 · high $197.51Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
📊 JPI status : Align Technology has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 ALGN price target & analyst consensusprice $159

The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$240+51.1%
Median target · of 6 targets$214.5+35.0%
Lowest target · 1 firm of 6$188+18.4%
Current price$158.84
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 6100% $188 ↔ $240
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital73% of its targets hit on this sector (239 calls tested). It aims for $209 (+32 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).

The 1 reliable analyst $209+32 %
The 5 other firms $220+39 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $209 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy583%
Hold117%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Align Technology? The JPI assistant answers using our backtest data.

📈 Align Technology fundamentals: valuation, margins & growth › open the full page

P/E 27.6Net margin 10.0 %Revenue growth +4.3 %Average P/E

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 10 %
2023
Rev +3%Profit +23%
2024
Rev +4%Profit −5%
2025
Rev +1%Profit −3%

🔎 Detailed analyses

🏛️ Which US Congress members hold Align Technology (ALGN)?

1 Congress member has disclosed ALGN buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Josh Gottheimer · 56%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on ALGN

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Mizuho  100% +3.2% 2
Jefferies  89% +31.8% 9
Stephens & Co.  67% +21.5% 3
Baird  62% +25.4% 16
Goldman Sachs  62% +17.9% 8
Stifel  60% +27.8% 40
Barclays  60% +9.5% 5
SVB Leerink 57% +27.4% 7
B of A Securities  57% +1.9% 7
Morgan Stanley  56% +9.4% 18
See the other 11 firms
OTR Global 0% -13.6% 2
Evercore ISI Group  31% -14.6% 13
Wolfe Research  33% -21.7% 3
Wells Fargo  33% +4.3% 3
Leerink Swann 33% +33.9% 3
Piper Sandler  36% -6.3% 33
Credit Suisse 47% +10.8% 17
Berenberg  50% -11.9% 2
Cantor Fitzgerald  50% +0.8% 2
Barrington Research  50% +1.0% 2
UBS  50% +5.7% 6

📊 What $1,000 invested in Align Technology would be worth › open the full page

In short — $1,000 invested in Align Technology 10 years ago would be worth $2,561 today, i.e. +10%/yr on average. Best year: 2017 (+131%), worst: 2022 (-68%). Price performance, excluding dividends.

If I'd invested $1,000 in Align Technology

InvestmentWorth todayGain
1 years ago$809-19%
3 years ago$800-20%
5 years ago$316-68%
→ See Align Technology's full return history + gain calculator

Return by year (Align Technology)

YearReturn$1,000 invested at year start
2026 (YTD)+8%$1,080 (+8%)
2025-25%$809 (-19%)
2024-24%$616 (-38%)
→ See Align Technology's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Align Technology

Loading news…

📋 All analyst calls on ALGN

BMO Capital 
Jul 9, 26
▲ Outperform · 🎯$209
Price at call : $178.17 — upside +17%
Today : $158.84 — upside +32%
🎯 on ALGN : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Jul 9, 27
▲ Outperform · 🎯$220
Price at call : $178.91 — upside +23%
Today : $158.84 — upside +39%
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 30, 27
Morgan Stanley 
Apr 24, 26
■ Equal-Weight neutral · not a buy · 🎯$188
Price at call : $189.61 — gap to target -1%
Today : $158.84 — gap to target +18%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Apr 24, 27
Piper Sandler 
Apr 21, 26
▲ Overweight · 🎯$235
Price at call : $195.2 — upside +20%
Today : $158.84 — upside +48%
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Apr 21, 27
Citigroup 
Apr 15, 26
▲ Buy · 🎯$240
Price at call : $185.02 — upside +30%
Today : $158.84 — upside +51%
🎯 on ALGN : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 15, 27
Barclays 
Mar 17, 26
▲ Overweight · 🎯$200
Price at call : $176.12 — upside +14%
Today : $158.84 — upside +26%
🎯 on ALGN : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Mar 17, 27
Barclays 
Feb 26, 26
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $190.1 — gap to target +5%
Today : $158.84 — gap to target +26%
🎯 on ALGN : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 26, 27
HSBC 
Feb 9, 26
▲ Buy · 🎯$200
Price at call : $192.5 — upside +4%
Today : $158.84 — upside +26%
🎯 on ALGN : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Feb 9, 27
See the other 82 calls, newest to oldest
Stifel 
Feb 5, 26
▲ Buy · 🎯$210
Price at call : $187.6 — upside +12%
Today : $158.84 — upside +32%
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 5, 27
Piper Sandler 
Feb 5, 26
▲ Overweight · 🎯$220
Price at call : $187.6 — upside +17%
Today : $158.84 — upside +39%
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 5, 27
UBS 
Feb 5, 26
■ Neutral neutral · not a buy · 🎯$185
Price at call : $187.6 — gap to target -1%
Today : $158.84 — gap to target +16%
🎯 on ALGN : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 5, 27
▲ Outperform · 🎯$200
Price at call : $175.62 — upside +14%
Today : $158.84 — upside +26%
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Feb 5, 27
Wells Fargo 
Feb 5, 26
▲ Overweight · 🎯$200
Price at call : $175.62 — upside +14%
Today : $158.84 — upside +26%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 5, 27
■ Equal-Weight neutral · not a buy · 🎯$169
Price at call : $175.62 — gap to target -4%
Today : $158.84 — gap to target +6%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 5, 27
Mizuho 
Jan 20, 26
▲ Outperform · 🎯$200
Price at call : $165.55 — upside +21%
Today : $158.84 — upside +26%
🎯 on ALGN : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jan 20, 27
Barclays 
Dec 9, 25
■ Equal-Weight neutral · not a buy · 🎯$170
Price at call : $164.58 — gap to target +3%
Today : $158.84 — gap to target +7%
🎯 on ALGN : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 9, 26
Morgan Stanley 
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$154
Price at call : $137.88 — gap to target +12%
Today : $158.84 — gap to target -3%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Oct 30, 26
▲ Outperform · 🎯$170
Price at call : $137.88 — upside +23%
Today : $158.84 — upside +7%
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo 
Oct 30, 25
▲ Overweight · 🎯$181
Price at call : $137.88 — upside +31%
Today : $158.84 — upside +14%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Oct 30, 26
Piper Sandler 
Oct 30, 25
▲ Overweight · 🎯$200
Price at call : $138.43 — upside +44%
Today : $158.84 — upside +26%
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Oct 30, 26
Morgan Stanley 
Oct 21, 25
■ Equal-Weight neutral · not a buy · 🎯$142
Price at call : $135.58 — gap to target +5%
Today : $158.84 — gap to target -11%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Oct 21, 26
UBS 
Oct 16, 25
■ Neutral neutral · not a buy · 🎯$155
Price at call : $130.45 — gap to target +19%
Today : $158.84 — gap to target -2%
🎯 on ALGN : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 16, 26
Mizuho 
Oct 13, 25
▲ Outperform · 🎯$170
Price at call : $129.79 — upside +31%
Today : $158.84 — upside +7%
🎯 on ALGN : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Oct 13, 26
Jefferies 
Oct 10, 25
■ Hold neutral · not a buy · 🎯$140
Price at call : $125.79 — gap to target +11%
Today : $158.84 — gap to target -12%
🎯 on ALGN : 0% (1 call matured) · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Oct 10, 26
▲ Outperform · 🎯$160
Price at call : $133.09 — upside +20%
Today : $158.84 — upside +1%
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 8, 26
Stifel 
Jul 31, 25
▲ Buy · 🎯$200
Price at call : $136.52 — upside +46%
Today : $158.84 — upside +26%
Expected +46% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
+26.6%
stock +27% · XLV +24%
matured Jul 31, 26
Wells Fargo 
Jul 31, 25
▲ Overweight · 🎯$199
Price at call : $136.52 — upside +46%
Today : $158.84 — upside +25%
Expected +46% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
+26.6%
stock +27% · XLV +24%
matured Jul 31, 26
Piper Sandler 
Jul 31, 25
▲ Overweight · 🎯$190
Price at call : $136.52 — upside +39%
Today : $158.84 — upside +20%
Expected +39% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
+26.6%
stock +27% · XLV +24%
matured Jul 31, 26
Morgan Stanley 
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$154
Price at call : $129.01 — gap to target +19%
Today : $158.84 — gap to target -3%
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 31, 26
▲ Outperform · 🎯$220
Price at call : $200.48 — upside +10%
Today : $158.84 — upside +39%
Expected +10% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-11.1%
stock -11% · XLV +20%
matured Jul 9, 26
Wells Fargo 
May 1, 25
▲ Overweight · 🎯$246
Price at call : $179.82 — upside +37%
Today : $158.84 — upside +55%
Expected +37% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-4.4%
stock -4% · XLV +4%
matured May 1, 26
Piper Sandler 
May 1, 25
▲ Overweight · 🎯$250
Price at call : $179.82 — upside +39%
Today : $158.84 — upside +57%
Expected +39% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-4.4%
stock -4% · XLV +4%
matured May 1, 26
▲ Outperform · 🎯$200
Price at call : $176.74 — upside +13%
Today : $158.84 — upside +26%
Expected +13% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+1.2%
stock +1% · XLV +6%
matured May 1, 26
Needham 
May 1, 25
■ Hold neutral · not a buy
🎯 on ALGN : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 1, 26
Mizuho 
Apr 29, 25
▲ Outperform · 🎯$245
Price at call : $177.75 — upside +38%
Today : $158.84 — upside +54%
Expected +38% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
+0.4%
stock +0% · XLV +3%
matured Apr 29, 26
HSBC 
Apr 25, 25
■ Hold neutral · not a buy · 🎯$170
Price at call : $181.09 — gap to target -6%
Today : $158.84 — gap to target +7%
🎯 on ALGN : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Apr 25, 26
UBS 
Apr 24, 25
■ Neutral neutral · not a buy · 🎯$215
Price at call : $183.35 — gap to target +17%
Today : $158.84 — gap to target +35%
🎯 on ALGN : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 24, 26
Morgan Stanley 
Apr 15, 25
▲ Overweight · 🎯$249
Price at call : $167.18 — upside +49%
Today : $158.84 — upside +57%
Expected +49% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+10.7%
stock +11% · XLV +8%
matured Apr 15, 26
Mizuho 
Mar 25, 25
▲ Outperform · 🎯$250
Price at call : $170 — upside +47%
Today : $158.84 — upside +57%
Expected +47% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.5% (217 calls)
+6.0%
stock +6% · XLV +1%
matured Mar 25, 26
Piper Sandler 
Mar 18, 25
▲ Overweight · 🎯$235
Price at call : $166.14 — upside +41%
Today : $158.84 — upside +48%
Expected +41% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
+6.1%
stock +6% · XLV -0%
matured Mar 18, 26
Wells Fargo 
Feb 14, 25
▲ Overweight · 🎯$255
Price at call : $206.77 — upside +23%
Today : $158.84 — upside +61%
Expected +23% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-9.4%
stock -9% · XLV +9%
matured Feb 14, 26
▲ Outperform · 🎯$260
Price at call : $210.55 — upside +23%
Today : $158.84 — upside +64%
Expected +23% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-8.6%
stock -9% · XLV +7%
matured Feb 6, 26
▲ Overweight · 🎯$272
Price at call : $218.38 — upside +25%
Today : $158.84 — upside +71%
Expected +25% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-14.1%
stock -14% · XLV +7%
matured Feb 6, 26
Piper Sandler 
Feb 6, 25
▲ Overweight · 🎯$270
Price at call : $218.38 — upside +24%
Today : $158.84 — upside +70%
Expected +24% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-14.1%
stock -14% · XLV +7%
matured Feb 6, 26
Needham 
Feb 6, 25
■ Hold neutral · not a buy
🎯 on ALGN : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Feb 6, 26
Jefferies 
Jan 23, 25
▲ Buy · 🎯$260
Price at call : $233.3 — upside +11%
Today : $158.84 — upside +64%
Expected +11% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 0% (1 call matured) · 📊 on Health : 50.8% · +4.5% (380 calls)
-28.1%
stock -28% · XLV +10%
matured Jan 23, 26
▲ Outperform · 🎯$280
Price at call : $218.88 — upside +28%
Today : $158.84 — upside +76%
Expected +28% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
-23.4%
stock -23% · XLV +14%
matured Jan 6, 26
▼ Underperform · 🎯$206
Price at call : $230.09 — upside -10%
Today : $158.84 — upside +30%
Expected -10% · Actual -29% · Reason (≤ −15%) : ✓ Yes
🎯 on ALGN : 100% (1 call matured) · 📊 on Health : 48.3% · +2.0% (356 calls)
+29.3%
stock -29% · XLV +12%
matured Dec 13, 25
Needham 
Nov 4, 24
■ Hold neutral · not a buy
🎯 on ALGN : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Nov 4, 25
Morgan Stanley 
Oct 24, 24
▲ Overweight · 🎯$280
Price at call : $219.3 — upside +28%
Today : $158.84 — upside +76%
Expected +28% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 33% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-38.1%
stock -38% · XLV -1%
matured Oct 24, 25
Stifel 
Oct 24, 24
▲ Buy · 🎯$275
Price at call : $219.3 — upside +25%
Today : $158.84 — upside +73%
Expected +25% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-38.1%
stock -38% · XLV -1%
matured Oct 24, 25
▲ Outperform · 🎯$250
Price at call : $219.3 — upside +14%
Today : $158.84 — upside +57%
Expected +14% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-38.1%
stock -38% · XLV -1%
matured Oct 24, 25
Piper Sandler 
Oct 24, 24
▲ Overweight · 🎯$275
Price at call : $219.3 — upside +25%
Today : $158.84 — upside +73%
Expected +25% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-38.1%
stock -38% · XLV -1%
matured Oct 24, 25
Baird 
Oct 24, 24
▲ Outperform · 🎯$276
Price at call : $216.42 — upside +28%
Today : $158.84 — upside +74%
Expected +28% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-37.5%
stock -38% · XLV -2%
matured Oct 24, 25
Piper Sandler 
Oct 17, 24
▲ Overweight · 🎯$285
Price at call : $216.02 — upside +32%
Today : $158.84 — upside +79%
Expected +32% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-39.6%
stock -40% · XLV -6%
matured Oct 17, 25
Stifel 
Oct 11, 24
▲ Buy · 🎯$285
Price at call : $221.27 — upside +29%
Today : $158.84 — upside +79%
Expected +29% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-41.5%
stock -41% · XLV -8%
matured Oct 11, 25
▲ Outperform · 🎯$270
Price at call : $233.79 — upside +15%
Today : $158.84 — upside +70%
Expected +15% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-43.6%
stock -44% · XLV -6%
matured Oct 8, 25
Piper Sandler 
Sep 13, 24
▲ Overweight · 🎯$315
Price at call : $249.56 — upside +26%
Today : $158.84 — upside +98%
Expected +26% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-47.5%
stock -47% · XLV -13%
matured Sep 13, 25
Stifel 
Jul 25, 24
▲ Buy · 🎯$350
Price at call : $226.05 — upside +55%
Today : $158.84 — upside +120%
Expected +55% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-9.1%
stock -9% · XLV -8%
matured Jul 25, 25
Piper Sandler 
Jul 25, 24
▲ Overweight · 🎯$315
Price at call : $226.05 — upside +39%
Today : $158.84 — upside +98%
Expected +39% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-9.1%
stock -9% · XLV -8%
matured Jul 25, 25
Baird 
Jul 22, 24
▲ Outperform · 🎯$325
Price at call : $249.31 — upside +30%
Today : $158.84 — upside +105%
Expected +30% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-22.2%
stock -22% · XLV -10%
matured Jul 22, 25
Piper Sandler 
Jul 10, 24
▲ Overweight · 🎯$330
Price at call : $256.3 — upside +29%
Today : $158.84 — upside +108%
Expected +29% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-21.1%
stock -21% · XLV -8%
matured Jul 10, 25
Piper Sandler 
Jun 21, 24
▲ Overweight · 🎯$330
Price at call : $242.19 — upside +36%
Today : $158.84 — upside +108%
Expected +36% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-24.3%
stock -24% · XLV -10%
matured Jun 21, 25
▲ Outperform · 🎯$300
Price at call : $255.7 — upside +17%
Today : $158.84 — upside +89%
Expected +17% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-26.5%
stock -26% · XLV -8%
matured Jun 10, 25
Piper Sandler 
Apr 25, 24
▲ Overweight · 🎯$375
Price at call : $310.5 — upside +21%
Today : $158.84 — upside +136%
Expected +21% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-40.9%
stock -41% · XLV -1%
matured Apr 25, 25
Baird 
Apr 25, 24
▲ Outperform · 🎯$370
Price at call : $310.5 — upside +19%
Today : $158.84 — upside +133%
Expected +19% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-40.9%
stock -41% · XLV -1%
matured Apr 25, 25
Stifel 
Apr 18, 24
▲ Buy · 🎯$400
Price at call : $298.98 — upside +34%
Today : $158.84 — upside +152%
Expected +34% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-42.4%
stock -42% · XLV -5%
matured Apr 18, 25
Stifel 
Mar 15, 24
▲ Buy · 🎯$350
Price at call : $314.35 — upside +11%
Today : $158.84 — upside +120%
Expected +11% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-46.1%
stock -46% · XLV +1%
matured Mar 15, 25
Piper Sandler 
Mar 13, 24
▲ Overweight · 🎯$355
Price at call : $320.69 — upside +11%
Today : $158.84 — upside +123%
Expected +11% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-50.0%
stock -50% · XLV -2%
matured Mar 13, 25
Stifel 
Oct 26, 23
▲ Buy · 🎯$250
Price at call : $190.94 — upside +31%
Today : $158.84 — upside +57%
Expected +31% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
+13.0%
stock +13% · XLV +21%
matured Oct 25, 24
Stifel 
Oct 24, 23
▲ Buy · 🎯$390
Price at call : $253.69 — upside +54%
Today : $158.84 — upside +146%
Expected +54% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-14.7%
stock -15% · XLV +18%
matured Oct 23, 24
Stifel 
Aug 24, 23
▲ Buy · 🎯$430
Price at call : $356.35 — upside +21%
Today : $158.84 — upside +171%
Expected +21% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-35.0%
stock -35% · XLV +16%
matured Aug 23, 24
Stifel 
Apr 18, 23
▲ Buy · 🎯$390
Price at call : $356.37 — upside +9%
Today : $158.84 — upside +146%
Expected +9% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-15.4%
stock -15% · XLV +3%
matured Apr 17, 24
▲ Outperform · 🎯$375
Price at call : $343.1 — upside +9%
Today : $158.84 — upside +136%
Expected +9% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-19.7%
stock -20% · XLV +7%
matured Feb 2, 24
Stifel 
Feb 2, 23
▲ Buy · 🎯$375
Price at call : $359.88 — upside +4%
Today : $158.84 — upside +136%
Expected +4% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-23.9%
stock -24% · XLV +7%
matured Feb 2, 24
Baird 
Feb 2, 23
▲ Outperform · 🎯$335
Price at call : $359.88 — upside -7%
Today : $158.84 — upside +111%
Expected -7% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-23.9%
stock -24% · XLV +7%
matured Feb 2, 24
Stifel 
Oct 27, 22
▲ Buy · 🎯$265
Price at call : $188.62 — upside +40%
Today : $158.84 — upside +67%
Expected +40% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 17% (12 calls matureds) · 📊 on Health : 51.2% · +8.1% (299 calls)
-1.0%
stock -1% · XLV -7%
matured Oct 27, 23
Baird 
Oct 27, 22
▲ Outperform · 🎯$260
Price at call : $188.62 — upside +38%
Today : $158.84 — upside +64%
Expected +38% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-1.0%
stock -1% · XLV -7%
matured Oct 27, 23
▲ Outperform · 🎯$285
Price at call : $280.97 — upside +1%
Today : $158.84 — upside +79%
Expected +1% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+34.5%
stock +34% · XLV +1%
matured Jul 28, 23
Baird 
Jul 28, 22
▲ Outperform · 🎯$410
Price at call : $282.25 — upside +45%
Today : $158.84 — upside +158%
Expected +45% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+35.3%
stock +35% · XLV +2%
matured Jul 28, 23
Baird 
Apr 28, 22
▲ Outperform · 🎯$510
Price at call : $289.91 — upside +76%
Today : $158.84 — upside +221%
Expected +76% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+9.5%
stock +9% · XLV +3%
matured Apr 28, 23
▲ Outperform · 🎯$585
Price at call : $416.91 — upside +40%
Today : $158.84 — upside +268%
Expected +40% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-18.1%
stock -18% · XLV -3%
matured Apr 12, 23
▲ Outperform · 🎯$750
Price at call : $624.37 — upside +20%
Today : $158.84 — upside +372%
Expected +20% · Actual -69% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-68.9%
stock -69% · XLV -1%
matured Oct 28, 22
▲ Outperform · 🎯$680
Price at call : $620.45 — upside +10%
Today : $158.84 — upside +328%
Expected +10% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-19.4%
stock -19% · XLV +14%
matured Feb 4, 22
▲ Outperform · 🎯$625
Price at call : $526.46 — upside +19%
Today : $158.84 — upside +293%
Expected +19% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 25% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+18.4%
stock +18% · XLV +22%
matured Jan 4, 22
Baird 
Oct 22, 20
▲ Outperform · 🎯$450
Price at call : $469.56 — upside -4%
Today : $158.84 — upside +183%
Expected -4% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+25.6%
stock +26% · XLV +22%
matured Oct 22, 21
Baird 
Jun 10, 20
▲ Outperform · 🎯$325
Price at call : $238.28 — upside +36%
Today : $158.84 — upside +105%
Expected +36% · Actual +157% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+156.7%
stock +157% · XLV +28%
matured Jun 10, 21
Baird 
Jan 2, 20
▲ Outperform · 🎯$325
Price at call : $280.44 — upside +16%
Today : $158.84 — upside +105%
Expected +16% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+87.7%
stock +88% · XLV +12%
matured Jan 1, 21
Baird 
Jul 26, 19
▲ Outperform · 🎯$259
Price at call : $196.05 — upside +32%
Today : $158.84 — upside +63%
Expected +32% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+57.5%
stock +57% · XLV +15%
matured Jul 25, 20
Baird 
Mar 5, 19
▲ Outperform · 🎯$286
Price at call : $239.22 — upside +20%
Today : $158.84 — upside +80%
Expected +20% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ALGN : 50% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-1.9%
stock -2% · XLV +9%
matured Mar 4, 20

Frequently asked questions

Should I buy Align Technology stock?

This isn't buy advice. For Align Technology, the analyst consensus is "Buy", with an average price target of $215 (+35% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Align Technology). We show the numbers — you decide.

Is it too late to buy Align Technology? How high can it go?

The most bullish analyst target on Align Technology is $240 (+51% above today's price); the average is $215. That's the upside they see. Check how reliable those analysts have actually been on Align Technology on our site before trusting it.

Is Align Technology still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 21 analysts have a real record on Align Technology, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Align Technology? The case for and against

The arguments for and against, one by one, from the numbers: why invest in ALGN (and why hesitate).

What has Align Technology's past performance been?

Historical returns and a "how much if I had invested" calculator: ALGN performance & returns.

What is the best month to buy ALGN?

The 12 months ranked by the stock's past returns: best & worst month to buy ALGN.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)